Defining undifferentiated connective tissue diseases: A challenge for rheumatologists

Lupus

Volumn 17, Issue 4, 2008, Pages 278-280

  Mosca, Marta ^a   Tani, C ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; DIFFERENTIAL DIAGNOSIS; HUMAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; REVIEW; RHEUMATOLOGY;

AUTOIMMUNITY; CONNECTIVE TISSUE; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; HUMANS;

EID: 43249087025     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307088004     Document Type: Review

References (26)

1. LeRoy, EC, Maricq, HR, Kahaleh, MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341-343.
2. Ganczarczyk, L, Urowitz, MB, Gladman, DD. Latent lupus. J Rheumatol 1989; 16: 475-478.
3. Greer, JM, Panush, RS. Incomplete lupus erythematosus. Arch Intern Med 1989; 149: 2473-2476.
4. Alarcón, GS, Williams, GV, Singer, JZ, et al. Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue disease. J Rheumatol 1991; 18: 1332-1339.
5. Clegg, DO, Williams, JH, Singer, JZ, et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991;18: 1340-1343.
6. Mosca, M, Tavoni, A, Neri, R, Bencivelli, W, Bombardieri, S. Undifferentiated connective tissue diseases: the clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 1998; 7: 95-100.
7. Danieli, MG, Fraticelli, P, Franceschini, F, et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999; 17: 585-591.
8. Dijkstra, S, Nieuwenhuys, EJ, Swaak, AJ. The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 1999; 28: 33-37.
9. Williams, HJ, Alarcón, GS, Joks, R, et al. Early undifferentiated tissue disease. VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999; 26: 816-825.
10. Mosca, M, Neri, R, Bombardieri, S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17: 615-620.
11. Vila, LM, Mayor, AM, Valentin, AH, Garcia-Soberal, M, Vila, S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000; 9: 110-115.
12. Swaak, AJ, van de Brink, H, Smeenk, RJ, et al. Incomplete lupus erythematosus: results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology 2001; 40: 89-94.
13. Cavazzana, I, Franceschini, F, Belfiore, N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow up of 148 patients. Clin Exp Rheumatol 2001; 19: 403-409.
14. Mosca, M, Neri, R, Bencivelli, W, Tavoni, A, Bombardieri, S. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up of 5 years. J Rheumatol 2002; 29: 2345-2349.
15. Bodolay, E, Csiki, Z, Szekanecz, Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21: 313-320.
16. Mosca, M, Baldini, C, Bombardieri, S. Undifferentiated connective tissue diseases in the 2004. Clin Exp Rheumatol 2004; 22: S14-S18.
17. Mosca, M, Neri, R, Strigini, F, et al. Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus 2002; 11: 304-307.
18. Mosca, M, Tani, C, Bombardieri, S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007; 21: 1011-1023.
19. Lom-Orta, H, Alarcon-Segovia, D, Diaz-Jouanen, E. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. Rheumatology 1980; 7: 831-837.
20. Lockshin, MD. What is SLE? Editorial. J Rheumatol 1989; 16: 419-420.
21. Asherson, RA. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun Rev 2006; 6: 76-80.
22. Rand Mariq, H, Valter, I. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 2004; 22(Suppl. 33): S5-S13.
23. Martinez, JB, Valero, JS, Bautista, AJ, et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 2007; 25: 47-53.
24. Vandergheynst, F, Ocmant, A, Sordet, C, et al. Sibilia Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol 2006; 24: 129-133.
25. Tani, C, Mosca, M, d'Ascanio, A, et al. Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo 2006; 58: 212-218.
26. Doria, A, Mosca, M, Gambari, PF, Bombardieri, S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213-215.